OrganiGram Holdings Inc.
TSX VENTURE : OGI
OTCQB : OGRMF

OrganiGram Holdings Inc.

March 17, 2016 19:00 ET

OrganiGram Promotes Peter Hanson as Interim CFO

MONCTON, NEW BRUNSWICK--(Marketwired - March 17, 2016) -

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

OrganiGram Holdings Inc. (TSX VENTURE:OGI)(OTCQB:OGRMF) (the "Company") today announced that the company's current controller, Mr. Peter Hanson will assume the responsibility as interim CFO for Roger Rogers, who resigns effective March 17th, 2016 to pursue other business interests. This alignment from within continues to demonstrate OrganiGram's ideals of strong management and low SG&A overhead as we focus on growth in the coming quarters.

"Roger has made meaningful contributions to OrganiGram Holdings Inc. during the initial two-year startup phase of the organization," said CEO Denis Arsenault. During his tenure, Roger has built an excellent team, who have implemented tight financial controls and efficient processes that have helped us scale through the initial start up and establishment of the company. He leaves us with a strong foundation and an excellent team to see us through this next phase of our growth. Roger will remain as a consultant to the company during a transition phase and will remain as a member of the Board of Directors of OrganiGram Holdings Inc. Roger would like to thank "a tremendous team for their effort, dedication and hard work." We wish him the best in his new challenges working closer to his family in Saint John, NB.

About OrganiGram Holdings Inc.

OrganiGram Holdings Inc. is a TSX Venture Exchange listed company who's wholly owned subsidiary, OrganiGram Inc., is a licensed producer of medical marijuana in Canada. OrganiGram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. OrganiGram's facility is located in Moncton, New Brunswick and the Company is regulated by the Marihuana for Medical Purposes Regulations.

On behalf of the board of directors,

Denis Arsenault, Director and CEO

OrganiGram Holdings Inc.

The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, crop yields - that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information

  • OrganiGram Holdings Inc.
    Giselle Doiron
    Director of Investor and Media Relations
    (506) 801-8986
    www.organigram.ca